Top compounds associated with response to CAPG


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.14 1e-05
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.12 3e-05
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA Curcumin CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.14 4e-05
Download CSV